A retrospective comparison of varenicline monotherapy versus the combination of varenicline and bupropion or bupropion and nicotine patches in a va tobacco cessation clinic

Journal of Smoking Cessation

Volumn 6, Issue 1, 2011, Pages 65-73

  Shiltz, Dane ^a   Paniagua, Angie ^b   Hastings, James E ^b  

^a INDIANA UNIVERSITY HEALTH   (United States)

^b CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bupropion; Smoking; Smoking cessation; Tobacco use cessation; Tobacco use disorder; Varenicline

Indexed keywords

EID: 79958806452     PISSN: None     EISSN: 18342612     Source Type: Journal    
DOI: 10.1375/jsc.6.1.65     Document Type: Article

References (22)

1. Bedfont Scientific Ltd. (2008). Bedfont Smokerlyzer piCO+ page. Retrieved August 6, 2008, fromwww.bedfont. com/smokerlyzer/pico+
2. Chantix. (2008, May). Package insert. New York: Pfizer Labs.
3. Department of Veteran Affairs. (2007). Pharmacoeconomic analysis of varenicline, an a4b2nicotinic acetylcholine partial agonist, for smoking cessation at the Clement J. Zablocki Veterans Affairs Medical Center, Milwaukee, Wisconsin (Report). Milwaukee, WI: Author.
4. Ebbert, J.O., Croghan, I.T., Sood, A., Schroeder, D.R., Taylor Hays, J., & Hurt, R.D. (2009). Varenicline and bupropion sustained-release combination therapy for smoking cessation. Nicotine & Tobacco Research, 11, 234-239.
5. Fiore, M.C., Hatsukami, D.K., & Baker, T.B. (2002). Effective tobacco dependence treatment. JAMA, 288, 1768-1771.
6. Freedman, R. (2007). Exacerbation of schizophrenia by varenicline [Letter]. American Journal of Psychiatry, 164, 1269-1270.
7. Gold, P.B., Rubey, R.N., & Harvey, R.T. (2002). Naturalistic, self-assignment comparative trial of bupropion SR, a nicotine patch, or both for smoking cessation treatment in primary care. American Journal on Addictions, 11, 315-331.
8. Gonzales, D., Rennard, S.I., Nides, M., Azoulay, S., Billing, C.B., ... Reeves, K.R. (2006). Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation. JAMA, 296, 47-55.
9. Habitrol (1991, November). Package insert. Summit, NJ: Basel Pharmaceuticals.
10. Jamerson, B.D., Nides, M., Jorenby, D.E., Donahue, R., Garrett, P., Johnston, J.A., ... Leischow, S.J. (2001). Late-term smoking cessation despite initial failure: An evaluation of bupropion sustained-release, nicotine patch, combination therapy, and placebo. Clinical Therapeutics, 23, 744-52.
11. Jarvis, M.J., Tunstall-Pedoe, H., Feyerabend, C., Vesey, C., & Saloojee, Y. (1987). Comparison of tests used to distinguish smokers from nonsmokers. American Journal of Public Health, 77, 1435-1438.
12. Jorenby, D.E., Leischow, S.J., Nides, M.A., Rennard, S.I., Johnston, J.A., Hughes, A.R., ... Baker, T.B. (1999). A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. New England Journal of Medicine, 340, 685-691.
13. Jorenby, D.E., Hays, J.T., Rigotti, N.A., Azoulay, S., Watsky, E.J. Williams, K.E. et al. (2006). Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation. JAMA, 296, 56-63.
14. Kohen, I., & Kremen, N. (2007). Varenicline-induced manic episode in a patient with bipolar disorder. American Journal of Psychiatry, 164, 1269-1270.
15. Lowry, R. (2009). VassarStats: Web Site for Statistical Computation. Retrieved March 25, 2009, from http://faculty.vassar.edu/lowry/VassarStats.htm
16. Park, S.S., Lee, J.Y., & Cho, S.I. (2007). Validity of expired carbon monoxide and urine cotinine using dipstick method to assess smoking status. Journal of Preventive Medicine & Public Health, 40, 297-304.
17. Sato, S., Nishimura, K., Koyama, H., Tsukino, M., Oga, T., Hajiro, H., & Mishima, M. (2003). Optimal cutoff level of breath carbon monoxide for assessing smoking status in patients with asthma and COPD. Chest, 124, 1749-1754.
18. Steele, C. (1994). Is smoking a disease? Journal of Smoking-Related Disease, 5(Suppl. 1), 219-22.
19. Swanson, N.A., Burroughs, C.C., Long, M.A., & Lee, R.W. (2003). Controlled trial of smoking cessation in a Navy shipboard population nicotine patch, sustained-release bupropion, or both. Military Medicine, 168, 830-834.
20. Tonstad, S., Tonnesen, P., Hajek, P., Williams, K.E., Billing, C.B., & Reeves, K.R. (2006). Effect of maintenance therapy with varenicline on smoking cessation. JAMA, 296, 64-71.
21. United States Department of Health & Human Services. (2008). Treating tobacco use and dependence: 2008 update. Rockville, MD: Author.
22. Zyban. (2007, August). Package insert. Research Triangle Park, NC: GlaxoSmithKline.